Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

14.99USD
2 Jun 2015
Change (% chg)

-- (--)
Prev Close
$14.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
87,130
52-wk High
$18.47
52-wk Low
$12.36

RDSMY.PK

Chart for RDSMY.PK

About

Koninklijke DSM NV is a Netherlands-based science company, which is active in health, nutrition and materials sectors. It operates within three main business areas, namely Life Sciences, Materials Sciences and Innovation Center. The Life Sciences area comprises such segments, as Nutrition, which serves the food and beverage,... (more)

Overall

Beta: 1.82
Market Cap(Mil.): $10,584.26
Shares Outstanding(Mil.): 725.70
Dividend: 0.30
Yield (%): 3.20

Financials

  RDSMY.PK Industry Sector
P/E (TTM): 88.02 30.63 19.97
EPS (TTM): 0.17 -- --
ROI: 1.54 6.72 14.05
ROE: 1.84 7.56 15.86
Search Stocks

UPDATE 2-Top EU companies urge drastic cuts in greenhouse gas emissions

* Want tough action from Paris U.N. summit in December (Updates with quotes from Kerry, Fabius, DSM)

21 May 2015

BRIEF-DSM finalizes sale of DSM Synres to Standard Investment

* DSM Synres realizes sales of about 50 mln euro with around 80 employees

02 Apr 2015

UPDATE 1-DSM sells 65 percent stake in chemicals to CVC for at least 300 mln euros

* Deal will refocus company on less cyclical nutrition businesses

16 Mar 2015

DSM sells polymers, resins stake to CVC for at least 300 mln euros

AMSTERDAM, March 16 - Dutch supplements maker DSM said on Monday it will sell a 65 percent stake in two of its chemicals subsidiaries to CVC Capital Partners for at least 300 million euros ($316 million) in cash.

16 Mar 2015

BRIEF-DSM says CVC to invest in polymer intermediates, composite resins units

* Dsm and cvc announce partnership for polymer intermediates and composite resins

16 Mar 2015

DSM expects 2015 uplift despite low vitamin E prices and currency effects

AMSTERDAM - Dutch life sciences company DSM expects 2015 earnings to be higher than last year's despite low Vitamin E prices and negative currency effects, it said on Wednesday after posting fourth-quarter earnings and sales slightly ahead of estimates.

11 Feb 2015

UPDATE 2-DSM expects 2015 uplift despite low vitamin E prices and currency effects

* To combine 3 non-core units ahead of possible strategic actions

11 Feb 2015

DSM promises stronger 2015 despite low vitamin E prices, currency effects

AMSTERDAM, Feb 11 - DSM, a Dutch life sciences, materials and nutrition company, said it expected 2015 earnings to be higher than last year's despite low Vitamin E prices and negative currency effects, after posting fourth-quarter earnings and sales slightly ahead of estimates.

11 Feb 2015

BRIEF-DSM to sell Synres coating resins unit to Standard Investment

* All employees will on closing date transfer to new owner Source text for Eikon: Further company coverage:

17 Dec 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks